Clinical Trials on Respiratory Disease in Germany

Total 21649 results

Leti Pharma GmbH

Completed

Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients

Allergic Asthma | Allergic Rhinoconjunctivitis

Germany
Bitop AG

Completed

Effect of Ectoin® Inhalation Solution on Subjects With Mild Bronchial Asthma

Asthma

Germany
Bristol-Myers Squibb

Recruiting

A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer (FINN)

Carcinoma, Non-Small-Cell Lung

Germany
GlaxoSmithKline

Completed

723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover

Rhinitis, Allergic, Seasonal

Germany
Novartis
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects

Pandemic Influenza Disease

Finland, Germany
Charite University, Berlin, Germany

Completed

Safety Study of Levocetirizine and Fexofenadine (LAWAF)

Allergic Rhinitis | Pruritus | Chronic Urticaria

Germany
German Heart Institute
ETH Zurich

Completed

Robotic-assisted Exercise Training in Heart Failure

Pulmonary Disease | Heart Failure, Systolic

Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older

Influenza

Germany
GlaxoSmithKline

Completed

A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above

Influenza

Germany
ElectroCore INC

Completed

Study to Compare (COPD) Assessment Test in COPD Stage III and IV in a Prophylactic Treatment

Chronic Obstructive Pulmonary Disease

Germany
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above

Influenza

Germany
Universität des Saarlandes
MeMed Diagnostics Ltd.

Completed

Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2 (DIRECTOR)

COVID-19 | SARS-CoV-2 | Viral Infection

Germany
Universitätsklinikum Hamburg-Eppendorf

Terminated

Timing of Dilation Tracheostomy in Mechanically Ventilated Chronic Obstructive Pulmonary Disease (COPD) Patients

Pulmonary Disease, Chronic Obstructive

Germany
Heidelberg University

Completed

Implantation of Endobronchial Valves Versus Intrabronchial Valves in Patients With Severe Heterogeneous Emphysema

Pulmonary Emphysema

Germany
Pulmonx International Sàrl

Terminated

Long Term Follow up Investigation of Endobronchial Valves in Emphysema (LIVE)

Pulmonary Emphysema

Germany
Wissenschaftliches Institut Bethanien e.V
Merck Sharp & Dohme LLC; Institute of Pathology, University Clinic Düsseldorf

Completed

Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer

Lung Neoplasms

Germany
Technische Universität Dresden
Medical University of Vienna; University Hospital, Montpellier; University of... and other collaborators

Terminated

Variable Pressure Support Trial (ViPS)

Acute Lung Injury | Adult Respiratory Distress Syndrome | at Least 24 h of Controlled Mechanical Ventilation

Germany
bene-Arzneimittel GmbH
Medaimun GmbH

Completed

Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis (Tacho-COPD)

Pulmonary Disease, Chronic Obstructive | Bronchitis, Chronic

Germany
Boehringer Ingelheim

Completed

Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.

Pulmonary Disease, Chronic Obstructive | Asthma

Germany
Technische Universität Dresden

Unknown

Effect of an add-on Treatment With Ivy Leaves Dry Extract on Lung Function in Bronchial Asthma (HeHe)

Asthma

Germany
Johann Wolfgang Goethe University Hospital

Completed

Comparison of Two Methods of Bronchial Methacholine Provocation

Bronchial Hyperreactivity | Bronchial Asthma

Germany
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf; Robert Bosch Medical Center; Bernhard...

Terminated

Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY)

COVID-19

Germany
Ayham Daher

Recruiting

Effects of Pulmonary Diseases and Their Treatment on Cardiac Function

Idiopathic Pulmonary Fibrosis | COPD | Bronchial Asthma

Germany
Bayer

Completed

Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases

Respiratory System

Germany
German Institute of Human Nutrition
Charite University, Berlin, Germany; Freie Universität Berlin; German Center...

Recruiting

Breathing and Decision-Making (ProlEx-MRI)

Quality of Life | Stress, Psychological | Behavior

Germany
Charite University, Berlin, Germany

Recruiting

Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients

Covid19

Germany
Drägerwerk AG & Co. KGaA

Terminated

Dräger COVID-19 Antigen Test Clinical Performance Study

Covid19

Germany
University Hospital, Essen

Recruiting

PET-guided Radiotherapy for Patients With Small Cell Lung Cancer. (PET-ART)

Small Cell Lung Carcinoma

Germany
Charité Research Organisation GmbH
Bayer

Terminated

Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat (NICCAM)

Covid19

Germany
Pfizer

Completed

Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients. (A7881010)

Pulmonary Disease, Chronic Obstructive

Germany
Bavarian Nordic

Active, not recruiting

ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

COVID-19 Disease

Germany
Johann Wolfgang Goethe University Hospital

Completed

Influence of Nutrition on Nasal and Bronchial Affliction in Patients With Allergy on Grass-Pollen

Hypersensitivity | Allergy | Bronchial Hyperreactivity | Bronchial Asthma

Germany
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Influenza

Germany
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects

Influenza

Germany
AIO-Studien-gGmbH
AstraZeneca

Withdrawn

Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibitor Therapy (Re-Check)

NSCLC Stage IV

Germany
Stallergenes Greer
Venn Life Sciences

Completed

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

Allergy

Germany
University Hospital Tuebingen

Terminated

Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion

Pneumonia | Bacteremia

Germany
Goethe University

Completed

Evaluation of Sedation in COVID-19 ARDS

Severe Acute Respiratory Syndrome Coronavirus 2 | Prone Position | Pulmonary Ventilation | Hypnotics and Sedatives

Germany
Bitop AG

Completed

Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.

Acute Viral Pharyngitis

Germany
Allergopharma GmbH & Co. KG

Completed

Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

Birch Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis

Birch Pollen Allergy

Germany
University Hospital Tuebingen
Charite University, Berlin, Germany; Robert Bosch Gesellschaft für Medizinische...

Recruiting

Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID-19 Syndrome (YoFaPoCo)

Post-COVID-19 Syndrome | Fatigue Post Viral

Germany
AstraZeneca

Completed

Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Germany
AstraZeneca

Completed

A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Germany
Paracelsus Harz Clinic Bad Suderode.
Actelion

Completed

Prospective Study on Rehabilitation Patients With Pulmonary Hypertension and Other Pulmonary Diseases

Rehabilitation | Pulmonary Diseases

Germany
Pulmatrix Inc.

Completed

Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers

Chronic Obstructive Pulmonary Disease (COPD)

Germany
RWTH Aachen University

Completed

Inhalation Therapy in Ambulant and Hospitalized Patient Using Available Film Sequences From the Internet (InhaliPAD)

Asthma | COPD | Obstructive Lung Disease

Germany
Bayer
Novartis Pharmaceuticals

Completed

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany
Fisher and Paykel Healthcare

Terminated

Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany

Chronic Obstructive Pulmonary Disease | Obstructive Sleep Apnea | Obesity Hypoventilation Syndrome | Neuromuscular Disease

Germany
Corat Therapeutics Gmbh

Recruiting

Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19

Covid19

Germany

3

Subscribe